Top Drug Development Companies
8 Drug Development companies, sorted by total funding raised.
8
Companies
$561.2M
Combined Funding
Series C
Top Stage
Indexed tracks 8 Drug Development companies that have collectively raised $561.2M in documented funding. The most-funded drug development companies tracked include Galecto and Pharmion. Series C is the most common funding stage among drug development companies in this dataset.
Clinical-stage biotech developing small-molecule therapeutics targeting galectin and other mechan...
Biotechnology company focused on acquiring, developing and commercializing innovative products in...
Glycosylation by Design, Not Chance.
R&D company with 2 SBIR/STTR awards from Department of Health and Human Services.
.png)
Brenig is a small molecule drug development company that utilizes an AI/ML approach via a partner...
Developing disease-modifying nitro fatty acid platform technology for patients with fibrosis and ...
Frontage Laboratories is a global pharmaceutical contract research organization providing drug de...
Focused on discovery and development of therapeutic fusion proteins based on its proprietary Elas...
Frequently Asked Questions
How many Drug Development companies are tracked on Indexed?
Indexed tracks 8 Drug Development companies, sorted by total funding raised.
How much funding have Drug Development companies raised in total?
The Drug Development companies tracked by Indexed have collectively raised $561.2M in documented funding.
What are the top-funded Drug Development companies?
The most-funded Drug Development companies tracked include Galecto, Pharmion, Augment Biologics.
Explore More
Other Industries